直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Federal Circuit IP Blog

Anti-SLAPP Confers Jurisdiction for Interlocutory Appeals

November 5, 2025

Authored and Edited by Jillian M. Baggett; Wyatt L. Bazrod; Erik R. Puknys

In IQE PLC. v. Newport Fab, LLC, No. 2024-1124 (Fed. Cir. Oct. 15, 2025), the Federal Circuit vacated a district court decision denying defendant’s Anti-SLAPP motion.

The parties, IQE and Tower, previously negotiated for Tower to use IQE’s wafers in its semiconductor products. After negotiations fell through, IQE sued Tower for trade-secret violations, contending that it disclosed IQE’s confidential information in patent applications that were filed during (and shortly after) the parties’ negotiations. Tower moved to invoke California’s anti-SLAPP statute in response, arguing that filing for patent applications was an exercise of its constitutional right to petition the government. The district court denied the motion.

As an issue of first impression, the Federal Circuit first assessed whether it had jurisdiction over an interlocutory appeal from a district court’s denial of an anti-SLAPP motion to strike. Applying the “collateral order” three-factor test, the Federal Circuit held that it had jurisdiction, explaining that if Tower could not immediately appeal the order, the protection of the act would be irretrievably lost because Tower would have already incurred the burden of litigation by the time a final judgment was rendered.

After assessing jurisdiction, the Federal Circuit concluded that the district court improperly applied the Ninth Circuit’s anti-SLAPP two-step inquiry. Specifically, step one requires identifying the “protected activity,” which the district court framed as the possession of allegedly secret material. The Federal Circuit instead found that the correct question was whether the submission of that material in the patent applications was protected activity under the Anti-SLAPP statute. The Court concluded it was and remanded to the district court for further consideration of Tower’s motion.

Tags

jurisdiction

Related Practices

Appeals, Issues, and Legal Strategy

Federal Circuit and Supreme Court Appeals

Related Industries

AI, Electronics, and Information Technology

Electronic Devices and Components

Related Offices

Atlanta, GA

Palo Alto, CA

Contacts

Jillian M. Baggett
Associate
Atlanta, GA
+1 404 653 6441
Email
Wyatt L. Bazrod
Associate
Atlanta, GA
+1 404 653 6518
Email
Erik R. Puknys
Partner
Palo Alto, CA
+1 650 849 6644
Email

Copyright © 2025 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 

DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.

Related Insights

Lecture

IPIC/McGill Summer IP Course 2026: Understanding Trademarks

July 14, 2026

Montreal

Articles

Colorado Replaces Landmark AI Act: An Overview of the New SB 26-189 Framework

May 26, 2026

At the PTAB Blog

IPR and PGR Statistics for Final Written Decisions Issued in March and April 2026

May 26, 2026

At the PTAB Blog

Before the Holding, the Message: Director Squires Uses Magnolia Medical to Outline PTAB Discretionary Denial Policy Changes

May 20, 2026

Conference

19th Annual Forum on Pharma & Biotech Patent Litigation in Europe

May 19-20, 2026

Amsterdam

Webinar

Changes at the PTAB from Settled Expectations to Real Parties in Interest to Director Involvement

May 18, 2026

Webinar

Federal Circuit IP Blog

Federal Circuit Affirms § 102(b) Invalidity; Source Code Commands Are Not Hearsay

May 14, 2026

Federal Circuit IP Blog

When “and” and “e.g.” Matter: Federal Circuit Revives VLSI vs. Intel Case

May 14, 2026

Webinar

Implementation of Long-Arm Jurisdiction by the UPC Court and German National Courts: Strategic Considerations and Practical Implications

May 12, 2026

Webinar

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP